5-10
2026
影响因子区间
—
平台估算
29%
2025
中国作者发文占比
2760 USD;2270 GBP;2610 EUR
收费
期刊简介:The aims of the Journal of Neuroimmune Pharmacology are to promote the dissemination, interest, and exchange of new and important discoveries for the pharmacology and immunology of the nervous system. The aims parallel that of the Society on NeuroImmune Pharmacology by increasing the fundamental understanding of neurologic and neuropsychiatric disorders affected by the immune system or vice versa and towards pharmacologic measures that lead, either to a better understanding of disease mechanisms, or by improving disease outcomes. The scope of JNIP includes all primary works and reviews into the etiology, prevention, and treatment of neuroimmune and nervous system diseases affected by disordered immunity. Original studies serving to define neuroimmune modulation of environmental or endogenous cues such as toxins and drugs of abuse, hormones, and cytokines are welcome. JNIP will serve as a reliable source of interdisciplinary information bridging the fields of pharmacology, immunology, and neuroscience.
【译文】该期刊的目的是促进神经免疫药理学领域的新发现和重要发现的传播、兴趣和交流。其目标与神经免疫药理学学会的目标相一致,通过增加对受免疫系统或反之受影响的神经学和神经精神疾病的基本理解,以及通过改善疾病结果,推动对疾病机制的更好理解或通过药理学措施。JNIP的范围包括所有关于神经免疫和受免疫系统疾病影响的神经系统的病因、预防和治疗的原著作品和综述。欢迎提交旨在定义神经免疫调节环境或内源性线索(如毒素和滥用药物、激素和细胞因子)的研究。JNIP将成为连接药理学、免疫学和神经科学领域的可靠的多学科信息来源。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q1 | 暂无 |
| 影响因子区间 | 5-10 | 暂无 |